Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Tue Feb 3, 2:56AM CST

Jefferies analyst James Vane maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €36.00.

Claim 50% Off TipRanks Premium

Vane covers the Healthcare sector, focusing on stocks such as SCHOTT Pharma AG & Co. KGaA, Fresenius SE & Co. KGaA, and Gerresheimer. According to TipRanks, Vane has an average return of -1.0% and a 50.35% success rate on recommended stocks.

In addition to Jefferies, Fresenius Medical Care AG & Co. KGaA also received a Sell from Morgan Stanley’s Aisyah Noor in a report issued on January 27. However, on the same day, Barclays maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See the top stocks recommended by analysts >>

0H9X market cap is currently €11.02B and has a P/E ratio of 15.46.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).